Business Context and Reporting Period
Company: Helius Medical Technologies, Inc. (Note: Input metadata referenced "Solana Co," but the filing text identifies the registrant as Helius Medical Technologies, Inc., trading as HSDT on Nasdaq).
Filing Type: Form 8-K (Current Report)
Date of Report: September 15, 2025
Event: Entry into Material Definitive Agreements to raise capital via a private placement offering (PIPE) to fund a Solana (SOL) treasury strategy.
Key Financial Metrics and Transaction Terms
- Estimated Gross Proceeds: Approximately $500 million in cash (before fees and expenses).
- Offering Price (Cash Shares): $6.881 per share.
- Offering Price (Pre-Funded Warrants): $6.880 per warrant ($6.881 less $0.001).
- Stapled Warrant Exercise Price: $10.134 per share.
- Consideration Accepted:
- Cash Offering: U.S. dollars, USDC, or USDT.
- Cryptocurrency Offering: Unlocked or Locked SOL tokens.
- Use of Proceeds: Acquisition of SOL tokens via open market purchases, establishment of Solana treasury operations, working capital, and transaction fees.
- Management Fees (Trading Advisory):
- 1.0% per annum on AUM up to $1 billion.
- 0.75% per annum on AUM between $1 billion and $5 billion.
- 0.50% per annum on AUM over $5 billion.
Material Changes and Strategic Shifts
The filing details a significant strategic pivot from medical technologies to a cryptocurrency treasury model. Key changes include:
- Capital Structure: Issuance of Class A common stock, pre-funded warrants, and stapled warrants to accredited investors.
- Asset Composition: The company intends to hold SOL tokens as a primary treasury asset, managed by Pantera Capital.
- Leadership: Joseph Chee (controlling Summer Wisdom Holdings) is expected to be named Executive Chairman following the closing.
- Advisory Roles: Engagement of Pantera Capital and Summer Wisdom Holdings as strategic advisors for a 2-year initial term (auto-renewing).
Guidance, Risks, and Contingencies
- Closing Conditions: Expected closing on or about September 18, 2025, subject to customary conditions.
- Stockholder Approval: Required for the exercise of Cryptocurrency Pre-Funded Warrants and Strategic Advisor Warrants. A special meeting will be held post-closing.
- Lock-Up Periods:
- Cash Purchasers: Restricted from selling until the resale registration statement is effective, plus 30 days for 50% of securities.
- Cryptocurrency Purchasers: Restricted during the PIPE Lock-Up Period.
- Advisors: 180-day lock-up on shares underlying Strategic Advisor Warrants.
- Forced Exercise: The Company may require Stapled Warrants to be exercised if the stock price exceeds 200% of the offering price for 20 trading days in a 30-day period.
- Risks: The filing includes updated risk factors regarding the SOL treasury strategy, market volatility, and the ability to satisfy closing conditions. Forward-looking statements are subject to substantial uncertainties.
Investor Verification Checklist
- Verify the final closing date and total gross proceeds once the transaction settles.
- Confirm the outcome of the special stockholder meeting required to approve the exercise of cryptocurrency-related warrants.
- Review the Supplemental Risk Factors (Exhibit 99.3) for specific disclosures on cryptocurrency custody and volatility.
- Monitor the filing of the resale registration statement to determine the exact end of the lock-up periods for investors.
- Assess the impact of the 1.0% to 0.50% management fees on future net asset value as the treasury grows.